<?xml version="1.0"?><!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.0//EN" "http://www.ncbi.nlm.nih.gov:80/entrez/query/static/PubMed.dtd"><ArticleSet>
	<Article>
		<Journal>
			<PublisherName>John Libbey Eurotext</PublisherName>
			<JournalTitle>Annales de Biologie Clinique</JournalTitle>
			<Issn>0003-3898</Issn>
			<Volume>73</Volume>
			<Issue>4</Issue>
			<PubDate PubStatus="ppublish">
				<Year>2015</Year>
				<Month>08</Month>
				<Day>01</Day>
			</PubDate>
		</Journal>
		<ArticleTitle>A national survey about the French laboratory medicine</ArticleTitle>
		<VernacularTitle>L&#x02019;image de la biologie m&#x000E9;dicale et du biologiste m&#x000E9;dical aupr&#x000E8;s des Fran&#x000E7;ais&#x02026;</VernacularTitle>
		<FirstPage>397</FirstPage>
		<LastPage>398</LastPage>
		<AuthorList>
			<Author>
				<FirstName EmptyYN="N">Jean-Louis</FirstName>
				<LastName>Beaudeux</LastName>
				<Affiliation />
			</Author>
		</AuthorList>
		<PublicationType></PublicationType>
		<ArticleIdList>
			<ArticleId IdType="pii">abc.2015.1062</ArticleId>
			<ArticleId IdType="doi">10.1684/abc.2015.1062</ArticleId>
		</ArticleIdList>
		<History></History>
		<Abstract></Abstract>
	</Article>
	<Article>
		<Journal>
			<PublisherName>John Libbey Eurotext</PublisherName>
			<JournalTitle>Annales de Biologie Clinique</JournalTitle>
			<Issn>0003-3898</Issn>
			<Volume>73</Volume>
			<Issue>4</Issue>
			<PubDate PubStatus="ppublish">
				<Year>2015</Year>
				<Month>08</Month>
				<Day>01</Day>
			</PubDate>
		</Journal>
		<ArticleTitle>Chronic B-cell lymphoproliferative disorders with hairy cells</ArticleTitle>
		<VernacularTitle>Prolif&#x000E9;rations lympho&#x000EF;des B matures &#x000E0; cellules chevelues</VernacularTitle>
		<FirstPage>399</FirstPage>
		<LastPage>406</LastPage>
		<AuthorList>
			<Author>
				<FirstName EmptyYN="N">Xavier</FirstName>
				<LastName>Troussard</LastName>
				<Affiliation>Laboratoire d&#x02019;h&#x000E9;matologie, CHU C&#x000F4;te de Nacre, Caen, France</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">&#x000C9;douard</FirstName>
				<LastName>Cornet</LastName>
				<Affiliation>Laboratoire d&#x02019;h&#x000E9;matologie, CHU C&#x000F4;te de Nacre, Caen, France</Affiliation>
			</Author>
		</AuthorList>
		<PublicationType></PublicationType>
		<ArticleIdList>
			<ArticleId IdType="pii">abc.2015.1037</ArticleId>
			<ArticleId IdType="doi">10.1684/abc.2015.1037</ArticleId>
		</ArticleIdList>
		<History></History>
		<Abstract>The standardized blood smear examination is the first step in the diagnosis of a B-cell chronic lymphoproliferative disorder and can guide further investigations. In the laboratory, the identification of hairy cells on blood smear is a matter of daily practice. Hairy cell proliferations represent heterogeneous entities and their respective diagnoses can be difficult. If hairy cell leukemia (HCL) and splenic marginal zone lymphoma (SMZL) represent separate entities, the variant form of HCL (HCLv) and splenic diffuse red pulp small B-cell lymphoma (SDRPL) remain provisional entities in the 2008 WHO classification. We discuss the main clinical and biological characteristics of these four entities and appropriate means to characterize, identify and distinguish from each other; standardized blood smear examination, multiparameter flow cytometry analysis, analysis of the repertoire of immunoglobulins heavy chains genes and their mutational status (mutated or unmutated profile), molecular analyses: BRAF gene V600E mutation in HCL and MAP2K1 gene mutations in HCLv. We also discuss the main therapeutic aspects with emphasis on the new targeted drugs that enter into force in the therapeutic arsenal.</Abstract>
		<ObjectList>
			<Object Type="keyword">
				<Param Name="value">hairy cell leukemia</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">hairy cell leukemia-variant</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">splenic marginal zone lymphoma</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">splenic diffuse red pulp small B-cell lymphoma</Param>
			</Object>
		</ObjectList>
	</Article>
	<Article>
		<Journal>
			<PublisherName>John Libbey Eurotext</PublisherName>
			<JournalTitle>Annales de Biologie Clinique</JournalTitle>
			<Issn>0003-3898</Issn>
			<Volume>73</Volume>
			<Issue>4</Issue>
			<PubDate PubStatus="ppublish">
				<Year>2015</Year>
				<Month>08</Month>
				<Day>01</Day>
			</PubDate>
		</Journal>
		<ArticleTitle>Comparison of immunochromatographic tests Actim<sup>&#x000AE;</sup> Prom and Amnioquick<sup>&#x000AE;</sup> Duo for the rapid detection of premature rupture of membranes</ArticleTitle>
		<VernacularTitle>Comparaison des tests immunochromatographiques Actim<sup>&#x000AE;</sup> Prom et Amnioquick<sup>&#x000AE;</sup> Duo pour le d&#x000E9;pistage rapide de la rupture pr&#x000E9;matur&#x000E9;e des membranes</VernacularTitle>
		<FirstPage>407</FirstPage>
		<LastPage>411</LastPage>
		<AuthorList>
			<Author>
				<FirstName EmptyYN="N">Benjamin</FirstName>
				<LastName>Deckmyn</LastName>
				<Affiliation>Laboratoire, Groupe hospitalier de l&#x02019;Institut Catholique (GHICL), Lille, France</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Vincent</FirstName>
				<LastName>Chieux</LastName>
				<Affiliation>Laboratoire, Groupe hospitalier de l&#x02019;Institut Catholique (GHICL), Lille, France</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Franck</FirstName>
				<LastName>Ammeux</LastName>
				<Affiliation>Laboratoire, Groupe hospitalier de l&#x02019;Institut Catholique (GHICL), Lille, France</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Denis</FirstName>
				<LastName>Houze De L&#x02019;Aulnoit</LastName>
				<Affiliation>Service d&#x02019;obst&#x000E9;trique, Groupe hospitalier de l&#x02019;Institut Catholique (GHICL), Lille, France</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">G&#x000E9;rard</FirstName>
				<LastName>Forzy</LastName>
				<Affiliation>Laboratoire, Groupe hospitalier de l&#x02019;Institut Catholique (GHICL), Lille, France</Affiliation>
			</Author>
		</AuthorList>
		<PublicationType></PublicationType>
		<ArticleIdList>
			<ArticleId IdType="pii">abc.2015.1055</ArticleId>
			<ArticleId IdType="doi">10.1684/abc.2015.1055</ArticleId>
		</ArticleIdList>
		<History></History>
		<Abstract>Premature rupture of membranes (PRM) affects 5 to 15% of pregnancies, leading to prematurity and neonatal infection. PRM can be identified by through various amniotic fluid proteins in vaginal secretions. The aim of this study is to compare two immunochromatographic tests based on the detection of insulin-like growth factor binding protein (IGFBP-1) and alpha-foeto protein (AFP) for one of the two tests in cervico-vaginal secretions. Two tests, Actim<sup>&#x000AE;</sup> Prom and Amnioquick<sup>&#x000AE;</sup> Duo were performed on 80 pregnant women with suspected PRM. Amnioquick<sup>&#x000AE;</sup> Duo allows the simultaneous detection of IGFBP-1 and AFP with an automated incubation and reading. The number of positive results is similar (Khi-deux = 0.173, p = 0.6773) for IGFBP-1 between the two tests and there is a good agreement (K = 0.621), with a proportion of negative results of 86%. The number of positive results for AFP is more important in comparison to IGFBP-1. Results positive/positive (Actim<sup>&#x000AE;</sup> Prom/Amnioquick<sup>&#x000AE;</sup>) for IGFBP-1 seems to be related to the time when tests have been performed, that is to say in the last weeks of pregnancy. In conclusion, both tests have similar performance, but there is a risk of false positive results with AFP, this can be explained by the presence of non-visible blood in samples. An automated incubation and reading allows a good reproducibility. Moreover, the computer data storage improve the post-analytical quality.</Abstract>
		<ObjectList>
			<Object Type="keyword">
				<Param Name="value">premature rupture of membranes</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">IGFBP-1</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">AFP</Param>
			</Object>
		</ObjectList>
	</Article>
	<Article>
		<Journal>
			<PublisherName>John Libbey Eurotext</PublisherName>
			<JournalTitle>Annales de Biologie Clinique</JournalTitle>
			<Issn>0003-3898</Issn>
			<Volume>73</Volume>
			<Issue>4</Issue>
			<PubDate PubStatus="ppublish">
				<Year>2015</Year>
				<Month>08</Month>
				<Day>01</Day>
			</PubDate>
		</Journal>
		<ArticleTitle>Evaluation of the automated coagulation analyser Sysmex<sup>&#x000AE;</sup> CS-5100 (Siemens)</ArticleTitle>
		<VernacularTitle>&#x000C9;valuation de l&#x02019;automate d&#x02019;h&#x000E9;mostase Sysmex<sup>&#x000AE;</sup> CS-5100 (Siemens)</VernacularTitle>
		<FirstPage>413</FirstPage>
		<LastPage>419</LastPage>
		<AuthorList>
			<Author>
				<FirstName EmptyYN="N">Isabelle</FirstName>
				<LastName>Martin-Toutain</LastName>
				<Affiliation>UF d&#x02019;h&#x000E9;mostase, Service d&#x02019;h&#x000E9;matologie biologique, H&#x000F4;pital de la Piti&#x000E9;-Salp&#x000EA;tri&#x000E8;re-CFX, Paris, France</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Lionel</FirstName>
				<LastName>Jobic</LastName>
				<Affiliation>UF d&#x02019;h&#x000E9;mostase, Service d&#x02019;h&#x000E9;matologie biologique, H&#x000F4;pital de la Piti&#x000E9;-Salp&#x000EA;tri&#x000E8;re-CFX, Paris, France</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Tessy</FirstName>
				<LastName>Mancic</LastName>
				<Affiliation>UF d&#x02019;h&#x000E9;mostase, Service d&#x02019;h&#x000E9;matologie biologique, H&#x000F4;pital de la Piti&#x000E9;-Salp&#x000EA;tri&#x000E8;re-CFX, Paris, France</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Alexandre</FirstName>
				<LastName>Brissard</LastName>
				<Affiliation>UF d&#x02019;h&#x000E9;mostase, Service d&#x02019;h&#x000E9;matologie biologique, H&#x000F4;pital de la Piti&#x000E9;-Salp&#x000EA;tri&#x000E8;re-CFX, Paris, France</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Annick</FirstName>
				<LastName>Ankri</LastName>
				<Affiliation>UF d&#x02019;h&#x000E9;mostase, Service d&#x02019;h&#x000E9;matologie biologique, H&#x000F4;pital de la Piti&#x000E9;-Salp&#x000EA;tri&#x000E8;re-CFX, Paris, France</Affiliation>
			</Author>
		</AuthorList>
		<PublicationType></PublicationType>
		<ArticleIdList>
			<ArticleId IdType="pii">abc.2015.1054</ArticleId>
			<ArticleId IdType="doi">10.1684/abc.2015.1054</ArticleId>
		</ArticleIdList>
		<History></History>
		<Abstract>The Sysmex&#x000AE; CS-5100 is a fully automated multiparameter hemostasis analyzer equipped with a photo-optical clot detection unit, a cap-piercing system and a pre-analytical check screens for interfering substances such as bilirubin, lipids and haemolysis (HIL system). It is designed to perform coagulation tests as well as coagulometric, chromogenic and immunologic assays. The aim of the present study was to evaluate its performance. The intra-assay and inter-assay coefficients of variation (CV) were below 6% for most parameters both in the normal and in the pathological range (exceptions: intra-assay for severe factor VIII deficiency (CV = 7.4%) and for vWFRco (CV = 7.3% and 7.7%); and inter-assay for anti-Xa activity (CV = 8.8%) and vWFRco (9.3% and 11.1%). The measured lower limits of linearity for factor VIII and factor V were satisfactory. No sample or reagent carryover was detected in the conditions of the study. Our results demonstrated that using the Sysmex&#x000AE; CS-5100 analyzer, routine coagulation testing can be performed with satisfactory precision. This automate has the advantage of being connectable to an automation chain.</Abstract>
		<ObjectList>
			<Object Type="keyword">
				<Param Name="value">evaluation</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">hemostasis analyzer</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">Sysmex&#x000AE; CS-5100</Param>
			</Object>
		</ObjectList>
	</Article>
	<Article>
		<Journal>
			<PublisherName>John Libbey Eurotext</PublisherName>
			<JournalTitle>Annales de Biologie Clinique</JournalTitle>
			<Issn>0003-3898</Issn>
			<Volume>73</Volume>
			<Issue>4</Issue>
			<PubDate PubStatus="ppublish">
				<Year>2015</Year>
				<Month>08</Month>
				<Day>01</Day>
			</PubDate>
		</Journal>
		<ArticleTitle>Iron deficiency and pernicious anemia: a rare association?</ArticleTitle>
		<VernacularTitle>Carence martiale et maladie de Biermer&#x000A0;: une association rare&#x000A0;?</VernacularTitle>
		<FirstPage>420</FirstPage>
		<LastPage>426</LastPage>
		<AuthorList>
			<Author>
				<FirstName EmptyYN="N">Abrar-Ahmad</FirstName>
				<LastName>Zulfiqar</LastName>
				<Affiliation>D&#x000E9;partement de m&#x000E9;decine interne et g&#x000E9;riatrie, CHU Reims, France</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Moustapha</FirstName>
				<LastName>Dram&#x000E9;</LastName>
				<Affiliation>Unit&#x000E9; d&#x02019;aide m&#x000E9;thodologique, P&#x000F4;le recherche et innovations, CHU Reims, France</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Jean-Loup</FirstName>
				<LastName>Pennaforte</LastName>
				<Affiliation>D&#x000E9;partement de m&#x000E9;decine interne, CHU Reims, France</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Jean-Luc</FirstName>
				<LastName>Novella</LastName>
				<Affiliation>D&#x000E9;partement de m&#x000E9;decine interne et g&#x000E9;riatrie, CHU Reims, France</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Thomas</FirstName>
				<LastName>Vogel</LastName>
				<Affiliation>D&#x000E9;partement de m&#x000E9;decine interne et g&#x000E9;riatrie, CHRU Strasbourg, France</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Emmanuel</FirstName>
				<LastName>Andres</LastName>
				<Affiliation>D&#x000E9;partement de m&#x000E9;decine interne, CHRU Strasbourg, France</Affiliation>
			</Author>
		</AuthorList>
		<PublicationType></PublicationType>
		<ArticleIdList>
			<ArticleId IdType="pii">abc.2015.1056</ArticleId>
			<ArticleId IdType="doi">10.1684/abc.2015.1056</ArticleId>
		</ArticleIdList>
		<History></History>
		<Abstract>The aim of this study was to determine the prevalence of iron deficiency among patients with pernicious anemia. We realized a retrospective study from 2000 to 2010 including 55&#x000A0;patients suffering from pernicious anemia who were followed in Reims and Strasbourg university hospitals. Inclusion criteria were histological diagnosis of immune atrophic fundic gastritis and criteria of gastric autoimmuninty, and for which ferritin was measured. Iron deficiency is defined as serum ferritin level &#60;20&#x000A0;&#x003BC;g/L in women and &#60;30&#x000A0;&#x003BC;g/L in men. 45 (81.8%) patients were female. The mean age was 61&#x000A0;&#x000B1; 17&#x000A0;years (range: 25/98).There was anemia in 32&#x000A0;patients (58.2%). Macrocytosis was noted, with or without anemia, in 30&#x000A0;patients (54.5%); microcytosis, with or without anemia, was noted in 8 (14.5%) patients. 17&#x000A0;patients (30.9%) had normal mean corpuscular volume. Vitamin B12 deficiency was objectived in 42&#x000A0;patients (76.4%) in our series. 16&#x000A0;patients (29%) had iron deficiency. 14&#x000A0;patients were female. They were significantly younger than female subjects without iron deficiency (p =0.004). In conclusion, iron deficiency is not rare in patients with pernicious anemia. It could be a complication of achlorhydria. We suggest a dosage of serum ferritin for all patients with pernicious anemia.</Abstract>
		<ObjectList>
			<Object Type="keyword">
				<Param Name="value">pernicious anemia</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">anemia</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">iron deficiency</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">ferritin</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">mean corpuscular volume</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">cobalamin deficiency</Param>
			</Object>
		</ObjectList>
	</Article>
	<Article>
		<Journal>
			<PublisherName>John Libbey Eurotext</PublisherName>
			<JournalTitle>Annales de Biologie Clinique</JournalTitle>
			<Issn>0003-3898</Issn>
			<Volume>73</Volume>
			<Issue>4</Issue>
			<PubDate PubStatus="ppublish">
				<Year>2015</Year>
				<Month>08</Month>
				<Day>01</Day>
			</PubDate>
		</Journal>
		<ArticleTitle>Quantification of physiological aminoacids using aTRAQ<sup>&#x000AE;</sup> kit: evaluation and implementation of new markers</ArticleTitle>
		<VernacularTitle>Quantification des acides amin&#x000E9;s physiologiques par le kit aTRAQ<sup>&#x000AE;</sup>&#x000A0;: &#x000E9;valuation et impl&#x000E9;mentation de nouveaux param&#x000E8;tres</VernacularTitle>
		<FirstPage>427</FirstPage>
		<LastPage>442</LastPage>
		<AuthorList>
			<Author>
				<FirstName EmptyYN="N">Fran&#x000E7;ois</FirstName>
				<LastName>Boemer</LastName>
				<Affiliation>Laboratoire de biochimie g&#x000E9;n&#x000E9;tique, g&#x000E9;n&#x000E9;tique humaine, CHU de Li&#x000E8;ge, Universit&#x000E9; de Li&#x000E8;ge, Belgique</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Roland</FirstName>
				<LastName>Schoos</LastName>
				<Affiliation>Laboratoire de biochimie g&#x000E9;n&#x000E9;tique, g&#x000E9;n&#x000E9;tique humaine, CHU de Li&#x000E8;ge, Universit&#x000E9; de Li&#x000E8;ge, Belgique</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Michelle</FirstName>
				<LastName>Deberg</LastName>
				<Affiliation>Laboratoire de biochimie g&#x000E9;n&#x000E9;tique, g&#x000E9;n&#x000E9;tique humaine, CHU de Li&#x000E8;ge, Universit&#x000E9; de Li&#x000E8;ge, Belgique</Affiliation>
			</Author>
		</AuthorList>
		<PublicationType></PublicationType>
		<ArticleIdList>
			<ArticleId IdType="pii">abc.2015.1066</ArticleId>
			<ArticleId IdType="doi">10.1684/abc.2015.1066</ArticleId>
		</ArticleIdList>
		<History></History>
		<Abstract>Nowadays, physiological amino acids profiling is based primarily on ion exchange chromatography (IEC) coupled to a post-column derivatization with ninhydrin and UV detection at two wavelengths. Unfortunately, this technique suffers various drawbacks such as long analysis time, high sample volume and specific costs related to the maintenance of a dedicated equipment. These reasons have led us to consider a technology switch to a mass spectrometry method. We tested the kit aTRAQ amino acids analysis for physiological samples (AB Sciex), offering a selective quantification of more than 40 amino acids, and have implemented the acquisition of various original markers to the initial method. The accuracy profiles established for each amino acid show that the results are very reliable. The linearity is assured between 1 and 1.000&#x000A0;&#x003BC;mol/L for most analytes. Result comparison with IEC method showed good agreement. Reference ranges are similar to those defined for the IEC method and patients with inborn errors of metabolism were readily identified. The aTRAQ method offers a valid alternative to IEC method with several advantages: reduced sample volume, decreased run time and increased specificity. However, the procedure requires a thorough review of all chromatographic peaks, process that considerably lengthens the overall time of the procedure. Finally, financial and practical considerations of both techniques have to be counterbalanced before initiating any methodological transition.</Abstract>
		<ObjectList>
			<Object Type="keyword">
				<Param Name="value">inborn errors of metabolism</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">amino acids</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">mass spectrometry</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">aTRAQ</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">validation</Param>
			</Object>
		</ObjectList>
	</Article>
	<Article>
		<Journal>
			<PublisherName>John Libbey Eurotext</PublisherName>
			<JournalTitle>Annales de Biologie Clinique</JournalTitle>
			<Issn>0003-3898</Issn>
			<Volume>73</Volume>
			<Issue>4</Issue>
			<PubDate PubStatus="ppublish">
				<Year>2015</Year>
				<Month>08</Month>
				<Day>01</Day>
			</PubDate>
		</Journal>
		<ArticleTitle>Cardiometabolic and cardiorenal syndromes interactions in Algerian diabetic-hypertensive patient: interest of predictive multi-biomarkers strategy to renal dysfunction</ArticleTitle>
		<VernacularTitle>Interactions entre le syndrome cardiom&#x000E9;tabolique et le syndrome cardior&#x000E9;nal chez le patient alg&#x000E9;rien hypertendu-diab&#x000E9;tique&#x000A0;: int&#x000E9;r&#x000EA;t d&#x02019;une strat&#x000E9;gie multi-biomarqueurs pr&#x000E9;dictive d&#x02019;une dysfonction r&#x000E9;nale</VernacularTitle>
		<FirstPage>443</FirstPage>
		<LastPage>453</LastPage>
		<AuthorList>
			<Author>
				<FirstName EmptyYN="N">Houda</FirstName>
				<LastName>Zoubiri</LastName>
				<Affiliation>Universit&#x000E9; des sciences et de la technologie Houari Boumediene, Facult&#x000E9; des sciences biologiques, Laboratoire de biologie et physiologie des organismes, &#x000C9;quipe de bio&#x000E9;nerg&#x000E9;tique et m&#x000E9;tabolisme interm&#x000E9;diaire, Alger, Alg&#x000E9;rie, &#x000C9;cole nationale sup&#x000E9;rieure de Kouba, Alger, Alg&#x000E9;rie</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Ghouti</FirstName>
				<LastName>Kacimi</LastName>
				<Affiliation>Laboratoire de biochimie, CHU-H&#x000F4;pital Mohamed Seghir Nekache, Alger, Alg&#x000E9;rie</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">El Mahdi</FirstName>
				<LastName>Haffaf</LastName>
				<Affiliation>Service de m&#x000E9;decine nucl&#x000E9;aire, CHU-H&#x000F4;pital Mohamed Seghir Nekache, Alger, Alg&#x000E9;rie</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Brahim</FirstName>
				<LastName>Oudjit</LastName>
				<Affiliation>Service de diab&#x000E9;tologie, H&#x000F4;pital Mohamed Seghir Nekache, Alger, Alg&#x000E9;rie</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Naima</FirstName>
				<LastName>Adjroud</LastName>
				<Affiliation>Service de cardiologie, CHU-H&#x000F4;pital Mohamed Seghir Nekache, Alger, Alg&#x000E9;rie</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Elhadj-Ahmed</FirstName>
				<LastName>Koceir</LastName>
				<Affiliation>Universit&#x000E9; des sciences et de la technologie Houari Boumediene, Facult&#x000E9; des sciences biologiques, Laboratoire de biologie et physiologie des organismes, &#x000C9;quipe de bio&#x000E9;nerg&#x000E9;tique et m&#x000E9;tabolisme interm&#x000E9;diaire, Alger, Alg&#x000E9;rie</Affiliation>
			</Author>
		</AuthorList>
		<PublicationType></PublicationType>
		<ArticleIdList>
			<ArticleId IdType="pii">abc.2015.1059</ArticleId>
			<ArticleId IdType="doi">10.1684/abc.2015.1059</ArticleId>
		</ArticleIdList>
		<History></History>
		<Abstract>The coexistence of essential hypertension (EH) in type 2 diabetic (T2D) patients greatly enhances chronic kidney disease. Objectives: To assess the acute renal dysfunction in two cohorts of diabetic-hypertensive subjects. The inaugural pathology for each group is either T2D or EH. Patients and methods: The study was undertaken on 506 subjects who were divided in 5 groups according to age and sex: diabetic, hypertensive, diabetic- hypertensive (DH and HD) and healthy groups. Patients were phenotyped regarding their cardiometabolic syndrome (CMS) profile using the NCEP/ATPIII criteria and cardiorenal syndrome (CRS) according to the International kidney foundation. Hypertension was defined as systolic (SBP) and diastolic (DBP) blood pressure &#x02265; 140/90 mmHg, respectively. Insulin resistance (IR) was assessed by Homa-IR model. Glomerular filtration rate (GFR) by creatinine clearance. CMS and CRS parameters were determined on Cobas&#x000AE;. The SBP and DBP measurements by electronic blood pressure using Omron 705 CP&#x000AE; type. Results: IR was found in all diabetics and hypertensive patients. Dyslipidemia are correlated to % body fat mass accretion in all groups. In DH group, the renal disorder is confirmed by decreased GFR (30%) and increased microalbuminuria (&#x0003E; 30&#x000A0;mg/24h); associated with increased NT-pro BNP and plasma aldosterone depletion. Conclusion: Several biomarkers are necessary to detection kidney disease and renal failure prevention in diabetic patients to hypertensive state. The renal dysfunction was significantly related to T2D-EH disease.</Abstract>
		<ObjectList>
			<Object Type="keyword">
				<Param Name="value">essential hypertension</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">type 2 diabetes</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">insulinresistance</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">renal dysfunction</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">cardiometabolic syndrome</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">cardiorenal syndrome</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">reno-cardiac and metabolic biomarkers</Param>
			</Object>
		</ObjectList>
	</Article>
	<Article>
		<Journal>
			<PublisherName>John Libbey Eurotext</PublisherName>
			<JournalTitle>Annales de Biologie Clinique</JournalTitle>
			<Issn>0003-3898</Issn>
			<Volume>73</Volume>
			<Issue>4</Issue>
			<PubDate PubStatus="ppublish">
				<Year>2015</Year>
				<Month>08</Month>
				<Day>01</Day>
			</PubDate>
		</Journal>
		<ArticleTitle>Pre-analytical stability before centrifugation of 7 biochemical analytes in whole blood</ArticleTitle>
		<VernacularTitle>Impact sur le dosage en sang total de sept analytes biochimiques de la dur&#x000E9;e de conservation avant centrifugation des &#x000E9;chantillons</VernacularTitle>
		<FirstPage>454</FirstPage>
		<LastPage>460</LastPage>
		<AuthorList>
			<Author>
				<FirstName EmptyYN="N">Andreas</FirstName>
				<LastName>Perrier-Cornet</LastName>
				<Affiliation>D&#x000E9;partement de biochimie et pharmaco-toxicologie, H&#x000F4;pital de la Cavale-Blanche, CHRU, Brest, France</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Marie-Pierre</FirstName>
				<LastName>Moineau</LastName>
				<Affiliation>D&#x000E9;partement de biochimie et pharmaco-toxicologie, H&#x000F4;pital de la Cavale-Blanche, CHRU, Brest, France</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Val&#x000E9;rie</FirstName>
				<LastName>Narbonne</LastName>
				<Affiliation>P&#x000F4;le de biologie, H&#x000F4;pital de la Cavale-Blanche, CHRU, Brest, France</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Emmanuelle</FirstName>
				<LastName>Plee-Gautier</LastName>
				<Affiliation>D&#x000E9;partement de biochimie et pharmaco-toxicologie, H&#x000F4;pital de la Cavale-Blanche, CHRU, Brest, France, Laboratoire de neurosciences de Brest (LNB), Facult&#x000E9; de m&#x000E9;decine, Brest, France</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Fabienne</FirstName>
				<LastName>Le Saos</LastName>
				<Affiliation>D&#x000E9;partement de biochimie et pharmaco-toxicologie, H&#x000F4;pital de la Cavale-Blanche, CHRU, Brest, France</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Jean-Luc</FirstName>
				<LastName>Carre</LastName>
				<Affiliation>D&#x000E9;partement de biochimie et pharmaco-toxicologie, H&#x000F4;pital de la Cavale-Blanche, CHRU, Brest, France, Laboratoire de neurosciences de Brest (LNB), Facult&#x000E9; de m&#x000E9;decine, Brest, France</Affiliation>
			</Author>
		</AuthorList>
		<PublicationType></PublicationType>
		<ArticleIdList>
			<ArticleId IdType="pii">abc.2015.1060</ArticleId>
			<ArticleId IdType="doi">10.1684/abc.2015.1060</ArticleId>
		</ArticleIdList>
		<History></History>
		<Abstract>The pre-analytical stability of 7 biochemical parameters (parathyroid hormone -PTH-, vitamins A, C E and D, 1,25-dihydroxyvitamin D and insulin) at +4&#x000A0;&#x000B0;C, was studied on whole blood samples before centrifugation. The impact of freezing at -20&#x000B0;C was also analyzed/performed for PTH and vitamin D. The differences in the results of assays for whole blood samples, being kept for different times between sampling time and analysis, from 9 healthy adults, were compaired by using a Student t test. The 7 analytes investigated remained stable up to 4 hours at +4&#x000B0;C in whole blood. This study showed that it is possible to accept uncentrifuged whole blood specimens kept at +4&#x000B0;C before analysis. PTH is affected by freezing whereas vitamin D is not.</Abstract>
		<ObjectList>
			<Object Type="keyword">
				<Param Name="value">preservation</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">centrifugation</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">freezing</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">PTH</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">vitamin D</Param>
			</Object>
		</ObjectList>
	</Article>
	<Article>
		<Journal>
			<PublisherName>John Libbey Eurotext</PublisherName>
			<JournalTitle>Annales de Biologie Clinique</JournalTitle>
			<Issn>0003-3898</Issn>
			<Volume>73</Volume>
			<Issue>4</Issue>
			<PubDate PubStatus="ppublish">
				<Year>2015</Year>
				<Month>08</Month>
				<Day>01</Day>
			</PubDate>
		</Journal>
		<ArticleTitle>Contribution of the collagen binding activity (VWF:CB) in the range of tests for the diagnosis and classification of von Willebrand disease</ArticleTitle>
		<FirstPage>461</FirstPage>
		<LastPage>468</LastPage>
		<AuthorList>
			<Author>
				<FirstName EmptyYN="N">Meriem Yasmine</FirstName>
				<LastName>Ferhat-Hamida</LastName>
				<Affiliation>Centre de transfusion sanguine, CHU Bab Eloued, Alger, Alg&#x000E9;rie</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Houda</FirstName>
				<LastName>Boukerb</LastName>
				<Affiliation>Centre de transfusion sanguine, CHU Bab Eloued, Alger, Alg&#x000E9;rie</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Ghania</FirstName>
				<LastName>Hariti</LastName>
				<Affiliation>Centre de transfusion sanguine, CHU Bab Eloued, Alger, Alg&#x000E9;rie</Affiliation>
			</Author>
		</AuthorList>
		<PublicationType></PublicationType>
		<ArticleIdList>
			<ArticleId IdType="pii">abc.2015.1050</ArticleId>
			<ArticleId IdType="doi">10.1684/abc.2015.1050</ArticleId>
		</ArticleIdList>
		<History></History>
		<Abstract>Von willebrand disease (VWD) is a common inherited bleeding disorder. The diagnosis may need a large panel of tests that differ in term of sensibility and specificity, and because of the effect of multifactorial modifiers (genetic or environmental); there is difficulty in defining diagnostic limits. We performed a panel of tests on 19 patients suffering from recurrent bleeding, to diagnose and classify VWD subtypes, by introducing the von Willebrand factor (VWF) collagen binding test (VWF:CB), then comparing the results with the activity of VWF risticetin cofactor (VWF:RCo) and multimer pattern. We considered 30% limit rate of VWF, as described by many authors, to make the diagnosis of VWD. The diagnosis of type 1 of VWD has been confirmed in 7patients, subtype 2A in 2 patients, subtype 2M in 2 patients and type 3 in 2 patients. We also defined a new group of 6 patients named &#x0201C;uncertain type 1&#x0201D; that didn&#x02019;t fill into the type 1 diagnostic criterion. The comparison between VWF:CB and VWF:RCo showed good correlation for all types of VWD except for type 2 while comparison between VWF:CB and multimer pattern showed good concordance for all types of VWD diagnosed. In conclusion, VWF:CB can be a good alternative to VWF:RCo for the diagnosis of quantitative deficiencies of VWF. It can also replace the multimer pattern study. However, the introduction of VWF:CB didn&#x02019;t help in the diagnosis of the &#x0201C;uncertain type 1&#x0201D; group of patients and cannot be a replacement for qualitative defect.</Abstract>
		<ObjectList>
			<Object Type="keyword">
				<Param Name="value">von Willebrand disease</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">VWF:CB</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">von Willebrand factor</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">multimers</Param>
			</Object>
		</ObjectList>
	</Article>
	<Article>
		<Journal>
			<PublisherName>John Libbey Eurotext</PublisherName>
			<JournalTitle>Annales de Biologie Clinique</JournalTitle>
			<Issn>0003-3898</Issn>
			<Volume>73</Volume>
			<Issue>4</Issue>
			<PubDate PubStatus="ppublish">
				<Year>2015</Year>
				<Month>08</Month>
				<Day>01</Day>
			</PubDate>
		</Journal>
		<ArticleTitle>Genetic study in a tunisian family revealed IVS1+1G&#x0003E;A mutation in the CHM gene</ArticleTitle>
		<FirstPage>469</FirstPage>
		<LastPage>473</LastPage>
		<AuthorList>
			<Author>
				<FirstName EmptyYN="N">Ilhem</FirstName>
				<LastName>Ben Charfeddine</LastName>
				<Affiliation>Laboratoire de cytog&#x000E9;n&#x000E9;tique, g&#x000E9;n&#x000E9;tique mol&#x000E9;culaire et biologie de la reproduction humaines, CHU Farhat Hached, Sousse, Tunisie</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Taheni</FirstName>
				<LastName>Ben Lazreg</LastName>
				<Affiliation>Laboratoire de cytog&#x000E9;n&#x000E9;tique, g&#x000E9;n&#x000E9;tique mol&#x000E9;culaire et biologie de la reproduction humaines, CHU Farhat Hached, Sousse, Tunisie</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Narjes</FirstName>
				<LastName>Ben Rayana</LastName>
				<Affiliation>Service d&#x02019;ophtalmologie, CHU Farhat Hached, Sousse, Tunisie</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Abdelbasset</FirstName>
				<LastName>Amara</LastName>
				<Affiliation>Laboratoire de cytog&#x000E9;n&#x000E9;tique, g&#x000E9;n&#x000E9;tique mol&#x000E9;culaire et biologie de la reproduction humaines, CHU Farhat Hached, Sousse, Tunisie</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Ons</FirstName>
				<LastName>Mama&#x000EF;</LastName>
				<Affiliation>Laboratoire de cytog&#x000E9;n&#x000E9;tique, g&#x000E9;n&#x000E9;tique mol&#x000E9;culaire et biologie de la reproduction humaines, CHU Farhat Hached, Sousse, Tunisie</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Leila</FirstName>
				<LastName>Knani</LastName>
				<Affiliation>Service d&#x02019;ophtalmologie, CHU Farhat Hached, Sousse, Tunisie</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Amira</FirstName>
				<LastName>Mili</LastName>
				<Affiliation>Laboratoire de cytog&#x000E9;n&#x000E9;tique, g&#x000E9;n&#x000E9;tique mol&#x000E9;culaire et biologie de la reproduction humaines, CHU Farhat Hached, Sousse, Tunisie</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Ahlem</FirstName>
				<LastName>M&#x00027;sakni</LastName>
				<Affiliation>Laboratoire de cytog&#x000E9;n&#x000E9;tique, g&#x000E9;n&#x000E9;tique mol&#x000E9;culaire et biologie de la reproduction humaines, CHU Farhat Hached, Sousse, Tunisie</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Ali</FirstName>
				<LastName>Saad</LastName>
				<Affiliation>Laboratoire de cytog&#x000E9;n&#x000E9;tique, g&#x000E9;n&#x000E9;tique mol&#x000E9;culaire et biologie de la reproduction humaines, CHU Farhat Hached, Sousse, Tunisie</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Fafani</FirstName>
				<LastName>Ben Hadj Hamida</LastName>
				<Affiliation>Service d&#x02019;ophtalmologie, CHU Farhat Hached, Sousse, Tunisie</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Moez</FirstName>
				<LastName>Gribaa</LastName>
				<Affiliation>Laboratoire de cytog&#x000E9;n&#x000E9;tique, g&#x000E9;n&#x000E9;tique mol&#x000E9;culaire et biologie de la reproduction humaines, CHU Farhat Hached, Sousse, Tunisie</Affiliation>
			</Author>
		</AuthorList>
		<PublicationType></PublicationType>
		<ArticleIdList>
			<ArticleId IdType="pii">abc.2015.1052</ArticleId>
			<ArticleId IdType="doi">10.1684/abc.2015.1052</ArticleId>
		</ArticleIdList>
		<History></History>
		<Abstract>Choroideremia is a rare X-linked recessive, hereditary retinal pigment epithelial dystrophy, characterized by night blindness and progressive constriction of the visual fields leading to blindness in young adulthood. In this study, we reported three cases of choroideremia belonging to a Tunisian family. Patients complained of vision loss and night blindness. Fundus examination revealed diffused chorioretenal atrophy. In all cases, there was a visual field constriction and an undetectable electroretinography. Direct sequencing of the CHM gene detected a guanine to adenine transition (G&#x0003E;A) into the donor splice site of intron 1 leads to aberrantly spliced mRNA producing a premature stop codon and therefore functional loss of the CHM gene product, REP-1. The diagnosis should be considered in patients with a suitable family history and fundus findings.</Abstract>
		<ObjectList>
			<Object Type="keyword">
				<Param Name="value">choroideremia</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">CHM gene</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">Rab escort protein-1</Param>
			</Object>
		</ObjectList>
	</Article>
	<Article>
		<Journal>
			<PublisherName>John Libbey Eurotext</PublisherName>
			<JournalTitle>Annales de Biologie Clinique</JournalTitle>
			<Issn>0003-3898</Issn>
			<Volume>73</Volume>
			<Issue>4</Issue>
			<PubDate PubStatus="ppublish">
				<Year>2015</Year>
				<Month>08</Month>
				<Day>01</Day>
			</PubDate>
		</Journal>
		<ArticleTitle>Familial hypertriglyceridemia: biochemical, clinical and molecular study in a Moroccan family</ArticleTitle>
		<VernacularTitle>Hypertriglyc&#x000E9;rid&#x000E9;mie familiale&#x000A0;: &#x000E9;tude biochimique, clinique et mol&#x000E9;culaire dans une famille marocaine</VernacularTitle>
		<FirstPage>474</FirstPage>
		<LastPage>484</LastPage>
		<AuthorList>
			<Author>
				<FirstName EmptyYN="N">Mounya</FirstName>
				<LastName>Bouabdellah</LastName>
				<Affiliation>Laboratoire central de biochimie, CHU, Universit&#x000E9; Mohammed V Souissi Rabat, Maroc</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Hinde</FirstName>
				<LastName>Iraqi</LastName>
				<Affiliation>Service d&#x02019;endocrinologie et diab&#x000E9;tologie, Centre hospitalo-universitaire de Rabat, Maroc</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Pascale</FirstName>
				<LastName>Benlian</LastName>
				<Affiliation>Institut de biochimie et de biologie Mol&#x000E9;culaire, H&#x000F4;pital universitaire de Lille, France</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Ikram</FirstName>
				<LastName>Berqia</LastName>
				<Affiliation>Service d&#x02019;endocrinologie et diab&#x000E9;tologie, Centre hospitalo-universitaire de Rabat, Maroc</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Laila</FirstName>
				<LastName>Benchekroun</LastName>
				<Affiliation>Laboratoire central de biochimie, CHU, Universit&#x000E9; Mohammed V Souissi Rabat, Maroc</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Abdelmjid</FirstName>
				<LastName>Chra&#x000EF;bi</LastName>
				<Affiliation>Service d&#x02019;endocrinologie et diab&#x000E9;tologie, Centre hospitalo-universitaire de Rabat, Maroc</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Layachi</FirstName>
				<LastName>Chabraoui</LastName>
				<Affiliation>Laboratoire central de biochimie, CHU, Universit&#x000E9; Mohammed V Souissi Rabat, Maroc</Affiliation>
			</Author>
		</AuthorList>
		<PublicationType></PublicationType>
		<ArticleIdList>
			<ArticleId IdType="pii">abc.2015.1058</ArticleId>
			<ArticleId IdType="doi">10.1684/abc.2015.1058</ArticleId>
		</ArticleIdList>
		<History></History>
		<Abstract>Familial hypertriglyceridemia is a rare autosomal recessive inborn error of metabolism. Mutation within the LPL gene constitutes the first cause of monogenic etiology. Lipoprotein lipase (LPL) is the key enzyme in triglyceride-rich lipoproteins catabolism. Familial LPL deficiency is expressed by eruptive xanthomatosis and acute pancreatitis. We report a Moroccan case with a monstrous hypertriglyceridemia caused by LPL gene mutation. We discuss pathophysiology aspects according to available investigations data and the relevance of familial screening. The proband is a 19-year-old woman originating from the village of Taourirt (South of Morocco). She was admitted in emergency for diabetic ketoacidosis. Clinical investigations and routine laboratory tests were performed upon admission. Then lipoprotein electrophoresis and sequencing of the LPL gene were practiced. A monstrous hypertriglyceridemia up to 199 mmol/L was found. Lipoprotein electrophoresis has objectified profound disturbances on chylomicrons, VLDL and IDL. The sequencing detected a missense mutation p.S286R at homozygous state in a consanguinity context. Discovery of this LPL gene mutation is the first indigenous and documented case, never related in any other ethnic group. It constitutes a novel proof of a founder effect in the south Moroccan population. Prevalence studies with familial screening should be done for preventative action which is the only acceptable way to limit the cardiovascular and pancreatitis risks in this population where inbreeding is a general rule.</Abstract>
		<ObjectList>
			<Object Type="keyword">
				<Param Name="value">hypertriglyceridemia</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">chylomicronemia</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">lipoprotein lipase</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">LPL gene</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">p.S286R mutation</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">Moroccan founder effect</Param>
			</Object>
		</ObjectList>
	</Article>
	<Article>
		<Journal>
			<PublisherName>John Libbey Eurotext</PublisherName>
			<JournalTitle>Annales de Biologie Clinique</JournalTitle>
			<Issn>0003-3898</Issn>
			<Volume>73</Volume>
			<Issue>4</Issue>
			<PubDate PubStatus="ppublish">
				<Year>2015</Year>
				<Month>08</Month>
				<Day>01</Day>
			</PubDate>
		</Journal>
		<ArticleTitle>Biological disturbances during the lupus-associated pancreatitis: case report</ArticleTitle>
		<VernacularTitle>Les perturbations biologiques au cours de la pancr&#x000E9;atite lupique&#x000A0;: &#x000E0; propos d&#x02019;un cas</VernacularTitle>
		<FirstPage>485</FirstPage>
		<LastPage>490</LastPage>
		<AuthorList>
			<Author>
				<FirstName EmptyYN="N">Sanae</FirstName>
				<LastName>Sayagh</LastName>
				<Affiliation>Laboratoire central de biochimie, H&#x000F4;pital Ibn Sina, Centre hospitalier universitaire Rabat-Sal&#x000E9;, Rabat, Maroc, Facult&#x000E9; de m&#x000E9;decine et de pharmacie. Universit&#x000E9; Mohammed V Souissi-Rabat, Rabat, Maroc</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Leila</FirstName>
				<LastName>Benchekroun</LastName>
				<Affiliation>Laboratoire central de biochimie, H&#x000F4;pital Ibn Sina, Centre hospitalier universitaire Rabat-Sal&#x000E9;, Rabat, Maroc, Facult&#x000E9; de m&#x000E9;decine et de pharmacie. Universit&#x000E9; Mohammed V Souissi-Rabat, Rabat, Maroc</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Mounya</FirstName>
				<LastName>Bouabdellah</LastName>
				<Affiliation>Laboratoire central de biochimie, H&#x000F4;pital Ibn Sina, Centre hospitalier universitaire Rabat-Sal&#x000E9;, Rabat, Maroc, Facult&#x000E9; de m&#x000E9;decine et de pharmacie. Universit&#x000E9; Mohammed V Souissi-Rabat, Rabat, Maroc</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Nezha</FirstName>
				<LastName>Jaouhar</LastName>
				<Affiliation>Laboratoire central de biochimie, H&#x000F4;pital Ibn Sina, Centre hospitalier universitaire Rabat-Sal&#x000E9;, Rabat, Maroc</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Farida</FirstName>
				<LastName>El Aoufi</LastName>
				<Affiliation>Laboratoire central de biochimie, H&#x000F4;pital Ibn Sina, Centre hospitalier universitaire Rabat-Sal&#x000E9;, Rabat, Maroc</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Fatiha</FirstName>
				<LastName>El Oufir</LastName>
				<Affiliation>Laboratoire central de biochimie, H&#x000F4;pital Ibn Sina, Centre hospitalier universitaire Rabat-Sal&#x000E9;, Rabat, Maroc</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Meryem</FirstName>
				<LastName>Alaoui</LastName>
				<Affiliation>Service de m&#x000E9;decine interne A, H&#x000F4;pital Ibn Sina, Centre hospitalier universitaire Rabat-Sal&#x000E9;, Rabat, Maroc, Facult&#x000E9; de m&#x000E9;decine et de pharmacie. Universit&#x000E9; Mohammed V Souissi-Rabat, Rabat, Maroc</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Mohammed</FirstName>
				<LastName>Adnaoui</LastName>
				<Affiliation>Service de m&#x000E9;decine interne A, H&#x000F4;pital Ibn Sina, Centre hospitalier universitaire Rabat-Sal&#x000E9;, Rabat, Maroc, Facult&#x000E9; de m&#x000E9;decine et de pharmacie. Universit&#x000E9; Mohammed V Souissi-Rabat, Rabat, Maroc</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Layachi</FirstName>
				<LastName>Chabraoui</LastName>
				<Affiliation>Laboratoire central de biochimie, H&#x000F4;pital Ibn Sina, Centre hospitalier universitaire Rabat-Sal&#x000E9;, Rabat, Maroc, Facult&#x000E9; de m&#x000E9;decine et de pharmacie. Universit&#x000E9; Mohammed V Souissi-Rabat, Rabat, Maroc</Affiliation>
			</Author>
		</AuthorList>
		<PublicationType></PublicationType>
		<ArticleIdList>
			<ArticleId IdType="pii">abc.2015.1065</ArticleId>
			<ArticleId IdType="doi">10.1684/abc.2015.1065</ArticleId>
		</ArticleIdList>
		<History></History>
		<Abstract>We report in this paper the case of female patient, hypertriglyceridemia associated with milky serum and hyperglycemia have been the alarm signal of a lupus-associated pancreatitis, the confirmation of this entity was done with elevated rate of serum lipase activity. It is about a 33 years age female. She has as unique antecedent a lupus diagnosed on January of the same. The patient was admitted on august 2013 for another episode of lupus associated to the lower lamb edema with a rate of C3 at 0.4 g/L (0.82-1,93) and C4 at 0.05 g/L (0.15-0.57). One day after the beginning of the corticotherapy, the patient presented hyperthermia, ataxis and behavior troubles, epigastric and articular pains and vomiting. Biochemical tests found hyperglycemia at 38.9 mmol/L (3.9-6.1), dyslipidemia with hypertriglyceridemia at 15.7 mmol/L (0.3-1.7) and total cholesterol rate at 5.2 mmol/L (&#60;5.2) associated with milky serum. Haematological tests objective normocytic normochromic anemia with 81 g/L of hemoglobin, lymphopenia at 0.88 G/L and normal platelet rate. Lupus associated pancreatitis was suggested and confirmed biologically with an hyperlipasemia at 180 UI/L (8-78) and radiologicaly with the image of focal hepatic steatosis. We conclude that on the presence of lupus, gastrointestinal and/or biological signs must motivate the measurement of the serum lipase activity as quickly as possible to assess the diagnosis of lupus-associated pancreatitis.</Abstract>
		<ObjectList>
			<Object Type="keyword">
				<Param Name="value">lupus-associated pancreatitis</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">hypertriglyceridemia</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">hyperglycemia</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">biological disturbance</Param>
			</Object>
		</ObjectList>
	</Article>
	<Article>
		<Journal>
			<PublisherName>John Libbey Eurotext</PublisherName>
			<JournalTitle>Annales de Biologie Clinique</JournalTitle>
			<Issn>0003-3898</Issn>
			<Volume>73</Volume>
			<Issue>4</Issue>
			<PubDate PubStatus="ppublish">
				<Year>2015</Year>
				<Month>08</Month>
				<Day>01</Day>
			</PubDate>
		</Journal>
		<ArticleTitle>Necrotizing pneumonia due to Streptococcus pneumoniae</ArticleTitle>
		<VernacularTitle>&#x000C0; propos d&#x02019;un cas de pneumopathie n&#x000E9;crosante &#x000E0; pneumocoque</VernacularTitle>
		<FirstPage>491</FirstPage>
		<LastPage>494</LastPage>
		<AuthorList>
			<Author>
				<FirstName EmptyYN="N">Anne</FirstName>
				<LastName>Limelette</LastName>
				<Affiliation>Laboratoire de bact&#x000E9;riologie-virologie-hygi&#x000E8;ne, CHU Reims, H&#x000F4;pital Robert Debr&#x000E9;, Reims, France, UFR M&#x000E9;decine, Universit&#x000E9; Reims Champagne-Ardenne, SFR CAP Sant&#x000E9; EA 4687, Reims, France</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Thomas</FirstName>
				<LastName>Guillard</LastName>
				<Affiliation>Laboratoire de bact&#x000E9;riologie-virologie-hygi&#x000E8;ne, CHU Reims, H&#x000F4;pital Robert Debr&#x000E9;, Reims, France, UFR M&#x000E9;decine, Universit&#x000E9; Reims Champagne-Ardenne, SFR CAP Sant&#x000E9; EA 4687, Reims, France</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Marie Laure</FirstName>
				<LastName>Boubee</LastName>
				<Affiliation>Service de r&#x000E9;animation, CHU Reims, H&#x000F4;pital Maison Blanche, Reims, France</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Jean S&#x000E9;bastien</FirstName>
				<LastName>Petit</LastName>
				<Affiliation>Service de r&#x000E9;animation, CHU Reims, H&#x000F4;pital Maison Blanche, Reims, France</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">V&#x000E9;ronique</FirstName>
				<LastName>Vernet-Garnier</LastName>
				<Affiliation>Laboratoire de bact&#x000E9;riologie-virologie-hygi&#x000E8;ne, CHU Reims, H&#x000F4;pital Robert Debr&#x000E9;, Reims, France, UFR M&#x000E9;decine, Universit&#x000E9; Reims Champagne-Ardenne, SFR CAP Sant&#x000E9; EA 4687, Reims, France</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Antoine</FirstName>
				<LastName>Grillon</LastName>
				<Affiliation>Laboratoire de bact&#x000E9;riologie-virologie-hygi&#x000E8;ne, CHU Reims, H&#x000F4;pital Robert Debr&#x000E9;, Reims, France</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Olivier</FirstName>
				<LastName>Toubas</LastName>
				<Affiliation>Service de radiologie, CHU Reims, H&#x000F4;pital Maison Blanche, Reims, France</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Christophe</FirstName>
				<LastName>De Champs</LastName>
				<Affiliation>Laboratoire de bact&#x000E9;riologie-virologie-hygi&#x000E8;ne, CHU Reims, H&#x000F4;pital Robert Debr&#x000E9;, Reims, France, UFR M&#x000E9;decine, Universit&#x000E9; Reims Champagne-Ardenne, SFR CAP Sant&#x000E9; EA 4687, Reims, France</Affiliation>
			</Author>
		</AuthorList>
		<PublicationType></PublicationType>
		<ArticleIdList>
			<ArticleId IdType="pii">abc.2015.1064</ArticleId>
			<ArticleId IdType="doi">10.1684/abc.2015.1064</ArticleId>
		</ArticleIdList>
		<History></History>
		<Abstract>We present a patient with a necrotizing pneumonia due to Streptococcus pneumoniae. This complication often affects children and is relatively rare and unrecognized in adults. Its diagnosis is often difficult on chest-X-ray and need a chest computed tomography. No risk factors predisposing to necrosis are described in literature and its mortality is not different from pneumonia without necrosis. The serotype 3 is the most common type implicated in pneumococcal necrotizing pneumonia. Study of virulence factors of S. pneumoniae and various genetic polymorphisms of the host should allow a better understanding of this complication.</Abstract>
		<ObjectList>
			<Object Type="keyword">
				<Param Name="value">Streptococcus pneumoniae</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">necrotizing pneumonia</Param>
			</Object>
		</ObjectList>
	</Article>
	<Article>
		<Journal>
			<PublisherName>John Libbey Eurotext</PublisherName>
			<JournalTitle>Annales de Biologie Clinique</JournalTitle>
			<Issn>0003-3898</Issn>
			<Volume>73</Volume>
			<Issue>4</Issue>
			<PubDate PubStatus="ppublish">
				<Year>2015</Year>
				<Month>08</Month>
				<Day>01</Day>
			</PubDate>
		</Journal>
		<ArticleTitle>Difficulties in interpreting the monoclonal gammopathy of chance discovery: transitional gammopathy case in a significant inflammatory syndrome</ArticleTitle>
		<VernacularTitle>Difficult&#x000E9;s d&#x02019;interpr&#x000E9;tation des gammapathies monoclonales de d&#x000E9;couverte fortuite&#x000A0;: cas d&#x02019;une gammapathie transitoire au cours d&#x02019;un syndrome inflammatoire important</VernacularTitle>
		<FirstPage>495</FirstPage>
		<LastPage>497</LastPage>
		<AuthorList>
			<Author>
				<FirstName EmptyYN="N">Raoul</FirstName>
				<LastName>Karfo</LastName>
				<Affiliation>Laboratoire central de biochimie, Ibn Sina, Rabat, Maroc</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Laila</FirstName>
				<LastName>Benchekroun</LastName>
				<Affiliation>Laboratoire central de biochimie, Ibn Sina, Rabat, Maroc</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Alban</FirstName>
				<LastName>Zohoun</LastName>
				<Affiliation>Laboratoire de biochimie, H&#x000F4;pital militaire d&#x02019;instruction Mohammed V, Rabat, Maroc</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Layachi</FirstName>
				<LastName>Chabraoui</LastName>
				<Affiliation>Laboratoire central de biochimie, Ibn Sina, Rabat, Maroc</Affiliation>
			</Author>
		</AuthorList>
		<PublicationType></PublicationType>
		<ArticleIdList>
			<ArticleId IdType="pii">abc.2015.1068</ArticleId>
			<ArticleId IdType="doi">10.1684/abc.2015.1068</ArticleId>
		</ArticleIdList>
		<History></History>
		<Abstract>The discovery of a monoclonal immunoglobulin is usually witnessed a malignant lymphoproliferative disease, but sometimes it is a transient event during viral, bacterial or fungal infections and during an inflammatory syndrome. Achieving electrophoresis performed in an elderly patient aged 55 with anemia to 63&#x000A0;g/L hemoglobin showed a consistent profile with intense inflammatory syndrome and chronic atypical with elevated C-reactive protein (CRP) greater than 300&#x000A0;mg/L (normal values: 0-8&#x000A0;mg/L) associated with the presence of two thin appearance monoclonal migrating bands in gamma position. Achieving immunofixation showed IgM kappa monoclonal confirmed by using betamercaptoethanol (BME). Radiological findings, hematological, revealed nothing. The recovery of blood away from the inflammation on another sample report presented a CRP at 5&#x000A0;mg/L and a subnormal profile electrophoresis and immunofixation revealed nothing. The comparison of the results of biochemical investigations, haematological and clinical and radiological control of the electrophoretic profile of a remote inflammatory syndrome to exclude cases of transient gammopathies.</Abstract>
		<ObjectList>
			<Object Type="keyword">
				<Param Name="value">electrophoresis</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">immunofixation</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">monoclonal gammopathy</Param>
			</Object>
		</ObjectList>
	</Article>
	<Article>
		<Journal>
			<PublisherName>John Libbey Eurotext</PublisherName>
			<JournalTitle>Annales de Biologie Clinique</JournalTitle>
			<Issn>0003-3898</Issn>
			<Volume>73</Volume>
			<Issue>4</Issue>
			<PubDate PubStatus="ppublish">
				<Year>2015</Year>
				<Month>08</Month>
				<Day>01</Day>
			</PubDate>
		</Journal>
		<ArticleTitle>ABO/D discrepancies in the era of automation and molecular immunohematology</ArticleTitle>
		<VernacularTitle>Les difficult&#x000E9;s de groupage ABO/D &#x000E0; l&#x02019;&#x000E8;re de l&#x02019;automatisation et de l&#x02019;immunoh&#x000E9;matologie mol&#x000E9;culaire</VernacularTitle>
		<FirstPage>499</FirstPage>
		<LastPage>507</LastPage>
		<AuthorList>
			<Author>
				<FirstName EmptyYN="N">Elias</FirstName>
				<LastName>Hamouche</LastName>
				<Affiliation>Centre m&#x000E9;dical libano-canadien, Beyrouth, Liban</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Olivier</FirstName>
				<LastName>Bouix</LastName>
				<Affiliation>Service d&#x02019;immunoh&#x000E9;matologie clinique, &#x000C9;tablissement fran&#x000E7;ais du sang, Montpellier, France</Affiliation>
			</Author>
		</AuthorList>
		<PublicationType></PublicationType>
		<ArticleIdList>
			<ArticleId IdType="pii">abc.2015.1063</ArticleId>
			<ArticleId IdType="doi">10.1684/abc.2015.1063</ArticleId>
		</ArticleIdList>
		<History></History>
		<Abstract>ABO/D grouping errors are still causing fatalities despite the substantial decrease observed over the past thirty years. This risk reduction is due, in part, to the increased automation of immunohematology techniques, a better control of clerical errors and a better knowledge of group discrepancies. The first part of the text will summarize the etiologies of group discrepancies while the second part will expose briefly the historical and technical evolution in immunohematology. Finally in the third part, the role of molecular techniques in immunohematology will be discussed.</Abstract>
		<ObjectList>
			<Object Type="keyword">
				<Param Name="value">grouping</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">discrepancy</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">automation</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">immunohematology</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">molecular</Param>
			</Object>
		</ObjectList>
	</Article>
	<Article>
		<Journal>
			<PublisherName>John Libbey Eurotext</PublisherName>
			<JournalTitle>Annales de Biologie Clinique</JournalTitle>
			<Issn>0003-3898</Issn>
			<Volume>73</Volume>
			<Issue>4</Issue>
			<PubDate PubStatus="ppublish">
				<Year>2015</Year>
				<Month>08</Month>
				<Day>01</Day>
			</PubDate>
		</Journal>
		<ArticleTitle>Pre-analytical recommendations for Xpert&#x000AE; Factor II &#38; Factor V (Cepheid): are the supplier&#x00027;s instructions too restrictive?</ArticleTitle>
		<VernacularTitle>Recommandations pr&#x000E9;-analytiques pour le test Xpert&#x000AE; Factor II &#38; Factor V (Cepheid) : les instructions du fournisseur sont-elles trop restrictives&#x000A0;?</VernacularTitle>
		<FirstPage>509</FirstPage>
		<LastPage>510</LastPage>
		<AuthorList>
			<Author>
				<FirstName EmptyYN="N">Emmanuel</FirstName>
				<LastName>Dedome</LastName>
				<Affiliation>H&#x000F4;pital d&#x02019;instruction des arm&#x000E9;es B&#x000E9;gin, F&#x000E9;d&#x000E9;ration de biologie clinique, Saint Mand&#x000E9;, France</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Sarah</FirstName>
				<LastName>Bugier</LastName>
				<Affiliation>H&#x000F4;pital d&#x02019;instruction des arm&#x000E9;es B&#x000E9;gin, F&#x000E9;d&#x000E9;ration de biologie clinique, Saint Mand&#x000E9;, France</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">El&#x000E9;onore</FirstName>
				<LastName>Fontan</LastName>
				<Affiliation>H&#x000F4;pital d&#x02019;instruction des arm&#x000E9;es B&#x000E9;gin, F&#x000E9;d&#x000E9;ration de biologie clinique, Saint Mand&#x000E9;, France</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Franck</FirstName>
				<LastName>Ceppa</LastName>
				<Affiliation>H&#x000F4;pital d&#x02019;instruction des arm&#x000E9;es B&#x000E9;gin, F&#x000E9;d&#x000E9;ration de biologie clinique, Saint Mand&#x000E9;, France</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Herv&#x000E9;</FirstName>
				<LastName>Delacour</LastName>
				<Affiliation>H&#x000F4;pital d&#x02019;instruction des arm&#x000E9;es B&#x000E9;gin, F&#x000E9;d&#x000E9;ration de biologie clinique, Saint Mand&#x000E9;, France</Affiliation>
			</Author>
		</AuthorList>
		<PublicationType></PublicationType>
		<ArticleIdList>
			<ArticleId IdType="pii">abc.2015.1053</ArticleId>
			<ArticleId IdType="doi">10.1684/abc.2015.1053</ArticleId>
		</ArticleIdList>
		<History></History>
		<Abstract></Abstract>
	</Article>

</ArticleSet>